QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future.
QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. The content we provide via Seeking Alpha may be part of our efforts to widen a client’s exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net.
Envoy Global, Inc., was founded in 2001 to pursue investment opportunities in turnaround and restructuring situations both in private and public companies. Casino Capitalism, the research arm of the company, periodically publishes reports on specific companies, as well as general articles on investment trends and psychology. You can read our reports at: www.CasinoCapitalism.com. Yehuda Fruchter, the editor-in-chief of Casino Capitalism, spent three years as part of Value Line’s equity analyst team before founding Envoy Global.
VFC is just a guy with an opinion. VFC's Stock House brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - the biotech, pharmaceutical and healthcare sectors. VFC's Stock House provides research, informational and opinion-based coverage of various companies and stocks in multiple sectors.
The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies. Do not Buy/Sell based solely on VFC's ideas or opinions.
The goal of VFC's Stock House is to 'call it like I see it' - while bringing new ideas, companies, and discussions to the eyes of investors and readers. This is supposed to be fun and new investors should not invest with the idea that this will 'pay the bills' or with the belief that a stock will just keep going up. DD is paramount, but so is sticking to pre-conceived entry and exit strategies and not letting emotional trading get in the way.
Goals must be realistic, if it sounds far fetched, then it probably is. Let the big boys eat the cake - the small investor is just trying to pick up some crumbs, and there's nothing wrong with that!
BestDamnPennys4Bucks.com is a multi-media marketing company that provides public awareness campaigns to increase liquidity for our client companies.
In addition, we predict the Hottest picks available in the industry for our members to invest their hard earned money in. Our picks are strategically designed to potentially make our subscribers huge monetary gains, pertaining to the penny stock market.
Mike Havrilla is a former pharmacist (retail and home infusion settings), biotech stock trader, and writer with experience that includes full-time online trading since 2009, working as a full-time pharmacist from 2004-2009, and writing for investors since 2007. Mike holds Doctor of Pharmacy (PharmD) and Bachelor of Science (Biology) degrees from the University of Pittsburgh and worked in the pharmaceutical industry for Wyeth prior to pharmacy school. He is also an avid runner and has completed over 20 marathons with a personal best time under three hours for the 26.2 mile race and under 80 minutes for the half marathon. Mike merged his former publishing business with BioRunUp.com / Mark Messier in October 2010, creating a new online biotech stock research and trading subscription service.
Paul is a stock investor with an accounting/finance background. He likes to look for value growth stocks and momentum news plays. He is also known as Superman on Twitter @super_trades and his blog is www.super-trades.com (http://www.super-trades.com).
Professionally licensed but commenting as an anonymous individual investor for informational and entertainment purposes only. Experienced in the industry since 1997 with an education in finance and economics. Prior to financial services industry, was a veteran of the armed services experienced in engineering and nuclear power operations.
TheStreetSweeper recently named Sonya Colberg as Senior Editor. About three years ago, she became senior investigative reporter of TheStreetSweeper, a website devoted to exposing fraud, shenanigans and lousy business practices of public companies. Sonya had worked more than two decades as an editor and reporter for two major newspapers, including the recent Warren Buffett acquisition, Tulsa World. Among others, the Associated Press, Great Plains Journalism Awards, The Gerald Loeb Awards and the Society of Professional Journalists have recognized Sonya’s investigative, feature, health, news and business stories. A fearless investigative reporter, Sonya loves nothing better than calling out the shysters and bumblers who quietly work to separate investors from their hard-earned money.
***The premium subscription portfolio returned 9.3% in less than a year, significantly outperforming major indexes. For a free trial of the paid subscription, please click on the orange "FREE TRIAL" link to learn more. If you would like to receive future free updates on interesting companies, please click the orange "Follow" button on any page showing one of my articles. The "Follow" button is located at the top of the page, next to my profile name and picture. Also, please make sure to learn more about my paid SeekingAlpha Marketplace subscription service and take advantage of the absolutely free trial.***
The subscription portfolio uses several diversification strategies and delivers returns with low correlation to the markets.
Martin Vlcek is a full-time investor and analyst who has been actively investing and managing money for more than 15 years. Martin has an Economics degree. Martin’s investment philosophy is to hold a truly diversified portfolio of investments across asset classes with low or negative correlation and a positive carry if possible. His primary stock investment focus is on undervalued small-cap stocks with favorable risk-to-reward ratio and upcoming catalysts.
Martin became a full-time investor and money manager after a 15-year career in online marketing where he was one of the pioneers of the pay-per-click search. Martin later held managerial positions at several Fortune 500 companies and also managed his own startup company.
IMPORTANT DISCLAIMER: Martin is not a Registered Investment Advisor, Broker/Dealer, Securities Broker or Financial Planner. The Information in his articles, his comment and his premium subscription service on SeekingAlpha.com or elsewhere is provided for information purposes only. The Information is not intended to be and does not constitute financial advice or any other advice, is general in nature and not specific to any individual. Before using Martin's information to make an investment decision, you should seek the advice of a qualified and registered securities professional and undertake your own due diligence. None of the information provided by Martin is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, company, or fund. Martin is not responsible for any investment decision made by you. You are responsible for your own investment research and investment decisions.
Damn Good Penny Picks is a private membership service that specializes in providing opinions, comments and information on stocks to individuals who wish to receive them. Our reports are for information purposes only.
For the past 30 years, I have been involved in startups, as a founder, and active investor. My first company was purchased by Johnson & Johnson, which set the foundation for future investments.
My level of trading escalated after graduating from college, primarily as a result of my relationship with the founder of the Silicon Valley venture capital firm, Institutional Venture Partners, (Netflix, Twitter, Oracle). By focusing on VC backed companies, I soon learned the advantage of investing in promising companies before they became household names. My interest in startups has never waned, and has become my primary focus today.
The Life Sciences Report features leading investment coverage of the life sciences sector, including biotechnology, pharmaceuticals, tools & diagnostics, and medical devices. A Streetwise Reports publication. www.TheLifeSciencesReport.com
I am business graduate with a professional certification in F&A. I have been associated with the academic field, teaching both short and long courses on Finance and Accounting but my passion is following and writing about good investments.
Have been successfully trading small cap stocks for the last fifteen years due to my willingness to learn and understand the minor details of technical analysis. Within the past year I have set up and managed one of the most up and coming small cap newsletters "SuperNova Alerts" from TopStockPicks website. My goal is to help educate new traders on the importance of chart reading and how this can be used to help improve your trading portfolio.
-I have been investing since the fall of 2008 and invested through one of the most difficult investing periods in history and know the importance of dividend growth and stability during those times as well as during the good times. I started writing for Seeking Alpha a little over three years ago and I have been successful with the companies I write about, which is shown by my high TipRanks success rate (Link Below). https://www.tipranks.com/bloggers/brad-kenagy
www.InvestorIdeas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas, news and research for biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on the TSX, OTC, NASDAQ and global stock exchanges. We have recently expanded our coverage to include Latin American markets.
Physician Assistant trained at State University of New York at Stony Brook. I am an Allied Fellow Member of the American Urological Association, Fellow of the American Academy of Physician Assistants, Fellow of the Urological Association of Physician Assistants, and former Vice President of the Adirondack Society of Physician Assistants (a Continuing Medical Education program). I am credentialed by the National Commission on the Certification of Physician Assistants (NCCPA)
My career is exclusively focused in surgery (urologic and general surgery) for the past 12 years, working with patients who receive chemotherapy, surgery, radiation, and active surveillance. My small rural practice (1 Physician, 1 Physician Assistant) is now an infusion center for Provenge. Small community practices are at the greatest risk of financial loss during Provenge treatment. My investment strategy with Provenge is closely guarded with a healthy amount of skepticism. I see the reality of the acceptability of Provenge, and other high-priced chemotherapies that have come to market in 2010-2011.
My practice does not perform prostate cancer surgery, chemotherapy, or radiation therapy. Therefore, as a general urology practitioner, I remain largely unbiased and I have served as a clinical opinion in many articles about DNDN and Provenge on seekingalpha.com, and continue to educate my patients and community physicians about Provenge as a treatment option.
GuruFundPicks.com offers top buy & sell picks based on the collective or Consensus Picks' of over 330 of our hand-picked top hedge & mutual fund managers, incl. 78 legendary or guru fund managers, 27 of the world's largest or mega funds, 165 sector-focused funds (in gold, biotech, tech, energy, consumer, finance & REITs), 59 billionaires, 54 new masters and 40 tiger, 52 shareholder activist and our Winners Circle Top 100 Performing Hedge Fund Managers (updated quarterly). We offer market-beating tools and services including Consensus Picks' DIY Tools, Top 20 Small-Cap and Top 30 All-Cap Long/Short Newsletters based on the Consensus Picks system, and Trade Alert Services for Self & Auto-Trading. All of our services have beaten market averages by wide margins. See our website GuruFundPicks.com for the latest performance numbers, or contact us at support@GuruFundPicks.com.
The two authors are co-managers of a family partnership long/short equity fund since 2001, that have a successful track record in trading primarily small-cap aggressive growth companies based on a fundamental valuation analysis of current news, including quarter reports, guidance, biotech clinical study results and other news. The junior partner is a self-taught private investor with a Business degree from the New York University's Leonard N. Stern School of Business and the senior partner has an MBA from the University of Virginia Darden School of Business, including prior MS & BS (Engg.) degrees, and with experience in business strategy consulting to large fortune 100 companies.
We are generally sector and market-cap agnostic, identifying opportunities using a 'stock picking' bottom-up, fundamentals-based, valuation-driven approach. However, we find most opportunities in the small-cap space, in technology & healthcare sectors, with some also found often in the consumer, energy & basic materials sectors.
Follow us on Seeking Alpha and Twitter (@GuruFundPicks), and connect with us on LinkedIn (http://www.linkedin.com/in/manishbabla)
Stock Market Media Group is a content driven investor relations firm. At Stock Market Media Group, we are focused on Research, Content Development and Awareness using the media to offer publicly traded companies maximum exposure while we tell their story. We offer corporate executives a platform to tell their story, while providing investors and traders an additional source of information when making decisions about future positions. Our website at www.stockmarketmediagroup.com is a growing library of content that includes, Research Reports, CEO interviews, Feature News Articles and more.
A Heisman trophy winner and Golden Spike candidate in college I was not. I was that fat kid in college who was good in math that all off you invited to your study groups so I could provide you with the solutions. After reading Body for Life, I transformed my physical self to match my real self and make hard core gains on penny stocks to match my hard core body. Of all the so-called gurus out there in penny land, there is only one authority on the subject I trust and that's the TMT group over at AimHighProfits.com. Trader by day, chef by night, if you want to change your life, both physical and financial, follow the path I took and you will be amazed at what a difference waking up in the morning is.
I grew up in NW Ohio, joined the Marines and stayed in the Carolinas after I got out of the service. Love to find under valued stocks, digging for info on public companies that fancy-pants analysts don't have the presence of mind to spot, and spending time with my family.
I recommend microcap (penny) stocks that I feel are in the "sweet spot" for nice trades to members of my service, "Microcap Millionaires". My website can be found at http://www.microcapmillionaires.com
I am the Portfolio Manager for the RETIREE INCOME PORTFOLIO, DIVIDEND OVERDRIVE PORTFOLIO, and the OIL & GAS INCOME PORTFOLIO at PortfolioChannel.com. I am also the creator of the Cash Flow Retirement Replacement Ratio© used in retirement and investment planning. A Chartered Financial Analyst and Certified Financial Planner, I have spent over two decades managing high-net worth individual and institutional accounts, working as a portfolio manager and analyst. I have also had several stints working for a pair of Private Banks managing balanced, fixed income, and equity accounts.
I am now trading independently and I hope that this will serve as a resource center as you research your own trades. I trade stock and options and mainly focus on event driven strategies such as mergers & acquisitions, biotechnology, and earnings. As I place trades in my portfolio, I will update my blog with the trade, price, and thought process.
Developer, Chief Strategist and Head Writer of AllanTrends.com, a trading service based upon a proprietary algorithm that identifies the dominant trend of any stock, index or ETF.